Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Supraclavicular block with bupivacaine plus magnesium sulfate, ketamine, or neostigmine in forearm orthopedic surgery
IRCT20141209020258N158Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative pain and acute pain comparing Bupivacaine + magnesium sulfate, Bupivacaine + ketamine and Bupivacaine + neostigmine (3 arms). Primary endpoints: Onset time of supraclavicular block, Duration of supraclavicular block and 1 more. Started May 2021; status: completed.
02
Drugs
bupivacainemagnesium sulfateketamineneostigmine
03
Conditions
postoperative painacute pain
Beyond the preview
Go deeper on IRCT20141209020258N158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N158.